# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-23-001743
Filing Date
2023-01-30
Accepted
2023-01-30 16:45:29
Documents
9
Period of Report
2023-01-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | arwr_xdef14ax316231.htm | DEF 14A | 1029346
2 |  | arrowhead_pagex1.jpg | GRAPHIC | 203705
3 |  | chart-0d38975edb3c464f8b6.jpg | GRAPHIC | 130338
4 |  | chart-c9c2bc9084654bd293a.jpg | GRAPHIC | 21071
5 |  | g298856g08m78.jpg | GRAPHIC | 50524
6 |  | g298856g27e04.jpg | GRAPHIC | 54665
7 |  | g298856g70d20.jpg | GRAPHIC | 68095
8 |  | proxycard1cc.jpg | GRAPHIC | 446798
9 |  | proxycard2cc.jpg | GRAPHIC | 181070
| Complete submission text file | 0001628280-23-001743.txt |  | 2623309

Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38042 | Film No.: 23568491
SIC: 2834 Pharmaceutical Preparations